New Delhi (India), July 26: West Bengal Chemical Industries Limited (WBCIL), a leading Indian pharmaceutical and nutraceutical API manufacturer, has made a remarkable debut at CPHI China 2024. CPHI China is one of the premier events for the global pharmaceutical industry. Despite the competitive pricing challenges posed by Chinese manufacturers, WBCIL’s participation proved to be a great move, yielding significant business opportunities and forging valuable connections.
Navigating a Competitive Market
China is renowned as a global chemical hub, offering products at highly competitive prices. Historically, this has made it challenging for Indian companies like WBCIL to penetrate the Chinese market, where imports from China often surpass Indian exports due to pricing disparities. Consequently, WBCIL had previously refrained from participating in CPHI China, doubting the feasibility of selling products in such a price-sensitive environment.
An International Participation in 2024
In 2024, WBCIL made a strategic decision to participate in CPHI China, not primarily to target the Chinese market, but to engage with the international clientele that frequents the exhibition. This bold move proved to be highly successful, attracting numerous clients from neighboring countries like Pakistan and Bangladesh to the WBCIL stand, resulting in a remarkably successful exhibition.
Success Beyond Expectations
The exhibition exceeded expectations, attracting significant interest from various international clients. Notably, Chinese companies expressed keen interest in WBCIL’s injectable irons and the newly developed oral iron API, Iron Sucrose. The immediate requests for samples and technical documentation for submission to the National Medical Products Administration (NMPA) highlighted the potential for WBCIL to make inroads into the Chinese market.
Future Prospects
WBCIL’s success at CPHI China 2024 marks a turning point, as the company now firmly establishes its presence in this competitive market. With new business avenues opening up in other countries, WBCIL plans to expand its participation in future exhibitions. Next year, the company aims to set up a larger stall at CPHI China, reflecting its growing confidence and commitment to exploring new opportunities.
Global Participation
WBCIL’s participation in CPHI China is part of its broader strategy of engaging in various global events to expand its market reach. The positive response received at the exhibition underscores the significance of such platforms in facilitating business growth and international collaborations.
As West Bengal Chemical Industries Limited continues to navigate the complex landscape of the pharmaceutical industry, its proactive approach and strategic participation in global events like CPHI China are set to propel the company to new heights, reinforcing its position as a leading player in the market.
About WBCIL
West Bengal Chemical Industries Limited (WBCIL), established in 1962 in Kolkata, India, is a distinguished leader in the pharmaceutical industry with over 62 years of expertise. Renowned for its high-quality APIs, WBCIL offers an extensive range of products, including injectable irons, chelated minerals, and nutraceutical, serving over 4,000 clients across 20+ countries. The company holds nine exclusive patents and prestigious certifications such as cGMP, ISO and FSSAI. With a robust annual capacity of 10,000 MT, WBCIL remains committed to innovation and excellence in API manufacturing.
